Celularity Inc (CELU)
2.76
-0.09
(-3.16%)
USD |
NASDAQ |
Nov 22, 16:00
2.77
+0.01
(+0.36%)
After-Hours: 20:00
Celularity Profit Margin (Quarterly): -53.57% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -53.57% |
| March 31, 2024 | -149.9% |
| December 31, 2023 | 78.82% |
| September 30, 2023 | -2.48K% |
| June 30, 2023 | -1.63K% |
| March 31, 2023 | -1.63K% |
| December 31, 2022 | |
| September 30, 2022 |
| Date | Value |
|---|---|
| June 30, 2022 | |
| March 31, 2022 | -1.06K% |
| December 31, 2021 | -83.20% |
| September 30, 2021 | |
| June 30, 2021 | -2.02K% |
| March 31, 2021 | -3.07K% |
| December 31, 2020 | |
| September 30, 2020 | -1.38K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.07K%
Minimum
Mar 2021
78.82%
Maximum
Dec 2023
-1.22K%
Average
-1.38K%
Median
Sep 2020
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Dentsply Sirona Inc | -51.95% |
| Ligand Pharmaceuticals Inc | -13.84% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -226.8% |
| Return on Assets | -68.23% |
| Return on Invested Capital | -128.9% |
| Gross Profit Margin (Quarterly) | 82.47% |
| Operating Margin (Quarterly) | -84.01% |
| Return on Net Operating Assets | -86.72% |